The Office of the Vice President for Research (OVPR) is pleased to announce the recipients of the 2022-23 SPARK Technology Commercialization Fund Program.
Five recipients were selected for internal funding through the program. They include researchers from UConn and UConn Health.
SPARK supports innovative proof-of-concept studies seeking to translate research discoveries into products, processes, and other commercial applications. The program’s primary goal is advancing primary faculty inventions toward the market, where they can have a positive impact for UConn, society, and Connecticut’s economy.
The 2022-23 awardees competed for funding in a highly selective process. Congratulations to the following:
Laijun Lai, UConn, Department of Allied Health Sciences
Targeting TAPBPL in antitumor immune therapy
Raman Bahal, UConn, Department of Pharmaceutical Science
Liver- and Kidney-targeted delivery of next generation miRNA inhibitors using carbohydrate-based conjugates
Eugene Pinkhassik, UConn, Department of Chemistry
Integration of palladium-catalyzed reactions in continuous manufacturing
Ali Tamayol, UConn Health, Department of Biomedical Engineering
Engineering a Handheld One-step Foaming and Printing Device for the Treatment of Soft Tissue Injuries
Luyi Sun, UConn, Department of Chemical and Biomolecular Engineering
High Performance Nanocoatings for Packaging Applications